The main function of the large intestine, aside from storage is to absorb water and salt from feces. Maybe you have a lot of background information about colon health issues and the different methods employed in the process. One of the most used and popular procedure in colon cleansing is the seven day colon cleanse program.

If you have never been in a colon cleansing program, it is very important that you have sufficient information and how can it be beneficial to your body and your overall health. Contrary to old belief, the bowel movements do not remove all feces entirely.

The restoration and maintenance of your overall health is generally dependent on the state of your digestion. Thus, colon cleansing is very essential when you want to have a healthy digestion and better lifestyle. In its simplest sense, colon cleansing improves the digestive system’s ability of breaking food particles, absorption of nutrients, water and salt and smooth elimination of fecal wastes. The end result of a successful colon cleansing is more energy and vigor.

Since colon cleansers focus on the colon itself it tends to give faster results. However, both procedures are employed to remove harmful body toxins from our body. They main benefits of a colon cleanser is that it aids you in losing weight, increase your body’s energy, cleansing your whole digestive system, breaks down fecal wastes accumulated in the colon, reduces bloating, decreases water retention and it maintains the smooth operation and functions of your colon and the rest of your body.

There are many methods of taking out these fecal waste build up in our colon. One of the easiest procedures is the combination of fiber rich food into your daily diet.

The best sources of fibers are grains, fruits and vegetables. However you can also take fiber supplements that are available in the market today.

Colon cleansing kits that are being marketed in the internet is not recommended by most dietitians and nutritionists. They are effective but they are expensive. The main ingredient of these cleansing products is licorice root, dandelion root or psyllium husk.  These organic materials are very high in fiber. You don’t need to pay at least a hundred dollars just to get a high intake of fiber. You can buy these ingredients in any health stores.

Nutritionists and dietitians suggest that colon congestion is a common result from different factors such as:

1. Colon parasites
2. Digestive overload from unhealthy foods such as red meat, junk foods, soda, white flour products and many more
3. Eating in a hurry
4. Lack of proper sleep
5. Lack of nutrients essential to digestive health such as fiber and water

Sometimes, the toxins taken out from colon cleansing flows in the skin resulting from rashes, acne and flu-like symptoms. Only a medical doctor or a colon specialist can say whether a person should undergo a colon cleansing procedure or the normal side effects.

It is also wise to note that the toxins that are released and taken out may take time than the actual fecal buildup, thus it is not recommended to keep on using the same colon cleanser just to experience less lethargy or shinier hair. If you would wait for that time, it might lead to another health problem as too much laxatives in your body is not good.

Paul Ritchie Inge runs Rank Bank.Our business rates the best business opportunities online.We try and look for things that will offer online entrepreneurs real profit opportunities and an education about how to make online profits.To see Rank Banks current Number 1 Pick just Click Here >>> Rank Banks Recommends Article Source

The “Drug Personality”

There is such a thing as a “drug personality.” It is artificial and is created by drugs. Drugs can change the attitude of a person from their original personality to one secretly harboring hostilities and hatreds they do not permit to show on the surface.

A person with a drug personality Pennsylvania may:

■Have mood swings
■Be unreliable
■Be unable to finish projects
■Have unexpressed resentment and secret hatreds
■Be dishonest and lie to family, friends and employers
■Isolate themselves and withdraw from those who love him
■Appear chronically depressed
■Begin stealing from family and friends

Craving is an extremely powerful urge and can cause a person to create all kinds of “reasons” they should continue using drugs or alcohol, even once they try to quit. The person is now trapped in the endless cycle of addiction Pennsylvania: trying to quit, craving, fear of withdrawal, relapse.

Treatment Focused on Breaking the Cycle of Addiction

Traditional alcohol and drug addiction treatment Pennsylvania focuses mainly on spiritual talk therapy, while the disease’s underlying physiology is never addressed. Modern, more effective treatments focus on correcting the neurological imbalances caused by substance dependence; those imbalances are the direct cause of cravings and withdrawal symptoms which, if left untreated, lead directly to relapse. This new approach, along with nutritional supplements and aftercare psychosocial counseling empowers the patient with the ability to stay on the road to recovery.

Since 1972, the renowned Clearbrook Treatment Centers have been providing effective treatment programs for adults and adolescents who suffer from alcoholism and/or chemical dependency. Clearbrook’s rehabilitation program is based upon the belief that alcoholism and chemical dependency is a primary disease and that the suffering addict and his or her family members deserve immediate help.

Article Source

Amyotrophic Lateral Sclerosis (Lou Gehrig’’s) – Drug Pipeline Analysis and Market Forecasts to 2016

This report provides key data, information and analysis on the amyotrophic lateral sclerosis (ALS) market. The report provides a comprehensive overview of the annualized market data from 2001 to 2009, and forecasts forward seven years to 2016. The research also includes market characterization, opportunities, the unmet needs associated with ALS, competitive assessment, product profiles of major marketed products and promising drugs in the pipeline, an overview on discontinued projects, implications for future market competition, and the key players of the ALS market. ( http://www.bharatbook.com/detail.asp?id=132806&rt=Amyotrophic-Lateral-Sclerosis-Lou-Gehrigs-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html )

The Amyotrophic Lateral Sclerosis Therapeutics Market is Forecast to Show Slow Growth to 2016
The global amyotrophic lateral sclerosis (ALS) therapeutics market was valued at $174m in 2009. It is expected to grow to $233m at a Compound Annual Growth Rate (CAGR) of 4.3% by 2016. This slow growth is attributed to the patent expiry of Rilutek in 2012 which is the only approved drug in the market for the treatment of ALS. The etiology is not known which poses significant challenges for prospective market entrants. The ageing population and the orphan drug status of the pipeline molecules will be the key drivers of this market.

Weak Market Served by One Approved Product for Treating ALS
It has analyzed the current market landscape and found it to be weak. There is only one FDA approved drug available in the market for the treatment of ALS. Although not a cure, Rilutek is the first and the only FDA approved drug which was approved in the US in 1995 and in 2001 in the EU. The exact mechanism of action of Rilutek in ALS is not known. However, it has an inhibitory effect on glutamate release. This antiglutamate drug has shown modest efficacy to prolong the life of patients with ALS by at least a few months. Clinical trial results demonstrated that the administration of Rilutek prolonged the survival of ALS patients by an average of 60-90 days. However, it has little or no effect on the progression of muscle weakness and on quality of life. Rilutek is manufactured by Aventis Pharmaceuticals. Based on the current market scenario, Rilutek has a monopoly in the market.

Poor Understanding of the Disease Leads to Low Diagnosis Rate
ALS is a progressive, paralyzing disease that is invariably fatal. The aetiology of ALS is poorly understood which poses a threat to any potential advances in the ALS market. As the cause of the disease is unknown, ALS is usually difficult to diagnose because it can appear to be a number of other neurological disorders, such as spinal cord tumors, multiple sclerosis, or nerve compression. This often leads to misdiagnosis of the disease. Physicians often experience a sense of helplessness and frustration in making an accurate diagnosis and in helping patients to cope with advancing disability and the prospect of death. There is a need to educate both the patients and the physicians.

A Lucrative Market with High Unmet Need
It finds that the global ALS market is a highly lucrative market with high unmet needs. The fact that the only product currently on the market does not serve the unmet needs of a larger therapeutic window, better efficacy and safety, and being suitable for a wider patient pool, results in the market presenting opportunities for stronger pipeline candidates. This historically static market offers huge potential for any drug maker whose drug can meet the unmet needs of the market. In addition, the orphan drug status of the pipeline molecules will result in the pharmaceutical companies investing in this highly lucrative market.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=132806&rt=Amyotrophic-Lateral-Sclerosis-Lou-Gehrigs-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

We are the leading information aggregator, facilitates and supports the business information needs. With over 115,000 reports, you can get instant access and insights on the studies in yo for market research , corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more ur areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com
Article Source

In childhood the most frequent rheumatological disease is juvenile rheumatoid arthritis which is also one of the most frequent chronic diseases in this age group. There are a number of different but related disorders which are expressed in chronic inflammation of the joints. It is not clear what causes these conditions and the complexity of the underlying genetic bases for them makes it difficult to clearly distinguish the different types. The naming of the diseases is also under review, with juvenile idiopathic arthritis perhaps gaining ground.

Three main divisions of juvenile rheumatoid arthritis can be described, that affecting many joints which is called polyarticular, that involving few joints and termed pauciarticular and a more body wide disease onset known as systemic arthritis. The arthritis is a chronic disease which flares up at times and then goes into remissions, with targeting of the medical treatment towards the induction and maintenance of a remission. Recent advances in the development of drugs have produced the biological agents which are much more effective for arthritic diseases.

How and why juvenile rheumatoid arthritis develops is not well understood, with an autoimmune attack against the tissues of the joints perhaps precipitated by infection or trauma. The lining of the joint, the synovial membranes, becomes larger and becomes chronically inflamed, with this occurring in individuals with some susceptibility of genetic origin. How the disease presents in the person and how it comes on is under the control of a number of genes. The incidence of these arthritic conditions is variable due to variations in influences from the environment, differences in the populations involved and in how susceptible individuals are.

Approximately fifty percent of all sufferers from juvenile chronic arthritis fall into the oligoarticular type with few joints affected, making it the most common type. With a greater number of joints affected by arthritis, the polyarticular type occurs in about a third of patients, with the remaining patients having the systemic form. Juvenile arthritis patients may be susceptible to acquiring a second autoimmune disorder. The significant disability and pain causes psychological distress, problems with behaviour, depression and anxiety. Girls are more likely to suffer from the many joint affected and poor joint affected forms, with equal incidence in the systemic form.

In terms of age, the few joint (oligoarticular) type occurs most commonly in children of two to four years in age, while the many joint (polyarticular) peaks at one to four years and also at six to twelve years. The systemic type can occur right through the childhood years. The division of juvenile chronic arthritis that a child belongs in is determined by the pattern of onset of the disease over the first six months. If four joints or fewer are involved then the child is classified into the oligoarticular chronic arthritis group. If a child has more than five joints affected in the six month period then they are recognised as being in the polyarticular type. The type which presents with a systemic onset comes on with the arthritis, fever and rashes.

If a diagnosis of juvenile arthritis of some form is to be made then the patient should have arthritis of some of their joints for at least six weeks. Stiffness in the morning or after periods when the joint has been kept still is a typical complaint. The start of the disease can be very sudden and dramatic or may come on slowly over some time, with common symptoms including stiffness of the joints as mentioned, joint pain in the day, periods of absence from school and a limping gait. Some patients also suffer from inflammatory disease of the bowel. A child may not always report actual pain in a joint but instead they may just allow the joint to go unused and develop atrophy or a joint contracture.

In the systemic form of juvenile arthritis the child suffers from fevers which spike once or twice a day at around the same time, the temperature typically returning back to normal each time. This pattern is different from infections so helps to distinguish what the patient is suffering from. These patients usually show a short lasting rash over the trunk and limbs, joint pain often in the bigger joints and appear to be unwell.

Jonathan Blood Smyth, editor of the Physiotherapy Site, writes articles about Physiotherapist, back pain, orthopaedic conditions, neck pain, injury management and Physiotherapists in London. Jonathan is a superintendant physiotherapist at an NHS hospital in the South-West of the UK.
Article Source